| Anti-HTN-Central Sympathoplegics |
|---|
| |
| |
|
| Anti-HTN-Ganglionic Blockers |
|---|
| |
| |
| |
|
| Anti-HTN-Nerve Terminal Blockers |
|---|
| |
| |
| |
| Heart Failure-Cardiac Glycosides |
|---|
| |
|
| Heart Failure-Beta Agonists |
|---|
| |
|
| Heart Failure-PDE Inhibitors |
|---|
| |
| |
| |
| |
|
| Heart Failure-Vasodilators |
|---|
| |
| |
| |
|
| Drug Classes used for Chronic Heart Failure |
|---|
| |
| |
| |
| |
| |
| |
|
| Drugs in Arrythmias-Group IA |
|---|
| |
| |
| |
|
| Drugs in Arrythmias-Group IB |
|---|
| |
| |
| |
|
| Drugs in Arrythmias-Group IC |
|---|
| |
| |
| |
|
| Drugs in Arrythmias-Group II |
|---|
| |
|
| Drugs in Arrythmias-Group III |
|---|
| |
| |
| |
| |
|
| Drugs in Arrythmias-Group IV |
|---|
| |
| |
| |
|
| Drugs in Arrythmias-Treats Dig Toxicity |
|---|
| |
|
| Drugs in Arrythmias-Opens K channels in AV node |
|---|
| |
|
| Vasoactive Peptides-Vasodilators |
|---|
| |
| |
| |
| |
| |
|
| Vasoactive Peptides-Vasoconstictors |
|---|
| |
| |
| |
| |
|
| Vasoactive Peptides-Mixed |
|---|
| |
|
| | | | |
| |
| Used to reverse Unfractionated Heparin |
|---|
| |
|
| Direct Thrombin Inhibitors |
|---|
| |
| |
| |
| |
| |
| Used to reverse Warfarin Toxicity |
|---|
| |
|
| Thrombolytics-tPa derivatives |
|---|
| |
| |
| |
| |
|
| Non-tPa derivative that acts on plasminogen |
|---|
| |
|
| Antiplatelet Drugs-COX Inhibitors |
|---|
| |
|
| Antiplatelet Drugs-ADP Receptor Antagonist |
|---|
| |
| |
| |
|
| Antiplatelet Drugs-GPIIa/IIIb Inhibitors |
|---|
| |
| |
| |
|
| Antiplatelet Drugs-PDE Inhibitors |
|---|
| |
| |
| |
| Used to increase vWf and Factor VIII |
|---|
| |
|
| Antiplatelet Drugs-ADP Receptor Antagonist |
|---|
| |
|
| | | | |
| Vasoactive Peptides-Vasoconstictors |
|---|
| |
| |
|